[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Dyne Therapeutics, Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:dyne-therapeutics.png) Dyne Therapeutics, Inc. Common Stock (DYN)

Dyne Therapeutics shares surge on positive DM1 trial data and analyst upgrades. However, valuation concerns and some downgrades are tempering gains.

### About Dyne Therapeutics, Inc. Common Stock
Dyne Therapeutics, Inc. Common Stock (DYN) is a publicly traded stock in the healthcare sector, focused on developing therapies for neuromuscular disorders.  
Dyne Therapeutics, Inc. Common Stock uses the ticker $DYN for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/dyne-therapeutics/insights)
- Dyne Therapeutics, Inc. Common Stock (DYN) market cap is up XXXXXX% from the previous X months.
- Dyne Therapeutics, Inc. Common Stock (DYN) social dominance is up XXXXXX% from the previous week.
- Dyne Therapeutics, Inc. Common Stock (DYN) creators is up XXXXX% from the previous week.
- Dyne Therapeutics, Inc. Common Stock (DYN) mentions is up XXXXX% from the previous week.
- Dyne Therapeutics, Inc. Common Stock Sentiment hit a 52-Week high of XXX for the day

### Price: $XXXXX [#](/topic/dyne-therapeutics/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/close.tsv)  
The current price action appears to be driven by positive clinical data and analyst ratings, leading to a recent increase in price, but tempered by valuation concerns.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| XXXX%   | XXXXX% | XXXXX% |

**1-Year High**: $XXXXX on 2024-10-19  
**1-Year Low**: $XXXX on 2025-04-08  
  
  
### AltRank: XXX [#](/topic/dyne-therapeutics/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/alt_rank.tsv)  
Dyne Therapeutics, Inc. Common Stock (DYN) is currently AltRank #146 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX -XXX  
**1 Month**: XXX -XX  
**6 Months**: XXX +107  
**1 Year**: XXX -XXXXX  
**1-Year High**: XXXXX on 2025-09-15  
**1-Year Low**: X on 2024-12-28  
  
  
### Galaxy Score: XXXXX [#](/topic/dyne-therapeutics/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -XX  
**1 Month**: XX -X  
**6 Months**: XX -XX  
**1 Year**: XX -XX  
**1-Year High**: XX on 2025-07-07  
**1-Year Low**: XX on 2024-11-26  
  
  
### Engagements: XXX [#](/topic/dyne-therapeutics/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXX -XX%  
**6 Months**: XXXXXXXXX +79%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-04-25  
**1-Year Low**: XXX on 2025-09-14  

| Social Network | X   | News | TikTok | YouTube |
| -------------- | -   | ---- | ------ | ------- |
| Engagements    | XXX | X    | X      | X       |
  

  
  
### Mentions: XX [#](/topic/dyne-therapeutics/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Week**: XXX +44%  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +46%  
**1 Year**: XXXXX +8.60%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: X on 2025-09-14  

| Social Network | X   | News | TikTok | YouTube |
| -------------- | -   | ---- | ------ | ------- |
| Mentions       | XXX | X    | X      | X       |
  

  
  
### Creators: XX [#](/topic/dyne-therapeutics/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Dyne Therapeutics, Inc. Common Stock (DYN) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XXX +31%  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +89%  
**1 Year**: XXXXX +77%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: X on 2025-09-14  

The most influential creators that mention Dyne Therapeutics, Inc. Common Stock in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)     | X    | XXXXXX    | X     | XXX         |
| [@Dyne_tx](/creator/twitter/Dyne_tx)             | X    | XXXXX     | X     | XX          |
| [@Biobeats99](/creator/twitter/Biobeats99)       | X    | XXX       | X     | XX          |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X    | XXXXX     | X     | X           |

[View More](/list/creators/dyne-therapeutics/100)
  
  
### Sentiment: XXX% [#](/topic/dyne-therapeutics/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +31%  
**6 Months**: XXX% +40%  
**1 Year**: XXX% +42%  
**1-Year High**: XXX% on 2025-10-18  
**1-Year Low**: XX% on 2025-01-04  

**Most Supportive Themes**
- **Positive Clinical Data and Breakthrough Designations:** (45%) Dyne Therapeutics' positive one-year clinical data from the ACHIEVE trial for DM1 and breakthrough designations are driving positive sentiment.
- **Analyst Ratings and Price Targets:** (25%) Favorable analyst ratings and price targets, with a consensus of Strong Buy and a potential upside, are supporting the stock.
- **Strong Institutional Confidence:** (15%) High institutional ownership and confidence from major funds are contributing to the positive outlook.
  
**Most Critical Themes**
- **Downgrades and Valuation Concerns:** (15%)  Downgrades from some analysts and concerns about valuation, despite promising clinical data, are creating some caution.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
| News    | X        | X%  | X       | X%  | X        | X% |
| TikTok  | X        | X%  | X       | X%  | X        | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/dyne-therapeutics/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXXX% +0.0045%  
**1 Month**: XXXX% -XXXXXXXXXXXXXXXXXXXXX%  
**6 Months**: XXXX% -XXXXX%  
**1 Year**: XXXX% -XXXXXX%  
**1-Year High**: XXXXX% on 2025-04-29  
**1-Year Low**: XXXXX% on 2025-09-14  
  
  
### Market Dominance: XXXXXXX% [#](/topic/dyne-therapeutics/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXXXX% on 2025-03-31  
**1-Year Low**: XXXXXXX% on 2025-04-11  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/dyne-therapeutics/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:dyne-therapeutics/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$22%  
**1 Month**: $XXXXXXXXXXXXX +$18%  
**6 Months**: $XXXXXXXXXXXXX +$120%  
**1 Year**: $XXXXXXXXXXXXX -$34%  
**1-Year High**: $XXXXXXXXXXXXX on 2024-10-19  
**1-Year Low**: $XXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Dyne Therapeutics, Inc. Common Stock in the last XX hours

[Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn)
[Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/sarepta-therapeutics-inc)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt)
[Akropolis (AKRO)](/topic/$akro)
[Arrowhead Research Corporation (ARWR)](/topic/$arwr)
[Never Forget (911)](/topic/$911)
[Edgewise Therapeutics, Inc. Common Stock (EWTX)](/topic/$ewtx)
[Devon Energy Corp (DVN)](/topic/devon-energy-corp)

**Top topics mentioned**
In the posts about Dyne Therapeutics, Inc. Common Stock in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$rna](/topic/$rna), [$pepg](/topic/$pepg), [japan](/topic/japan), [stocks](/topic/stocks), [investment](/topic/investment), [insider](/topic/insider), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [stocks technology](/topic/stocks-technology), [$srpt](/topic/$srpt), [$akro](/topic/$akro), [stocks financial services](/topic/stocks-financial-services), [market cap](/topic/market-cap), [stocks energy](/topic/stocks-energy), [fda](/topic/fda), [$arwr](/topic/$arwr), [$911](/topic/$911), [$pbmrf](/topic/$pbmrf), [stocks banks](/topic/stocks-banks), [$elvn](/topic/$elvn), [$ewtx](/topic/$ewtx), [monaco](/topic/monaco), [devon energy corp](/topic/devon-energy-corp), [$dvn](/topic/$dvn), [telegram](/topic/telegram), [$bpmc](/topic/$bpmc), [sec](/topic/sec), [bearish](/topic/bearish), [$lxeo](/topic/$lxeo), [$telo](/topic/$telo), [$kzia](/topic/$kzia), [long term](/topic/long-term), [$hsbc](/topic/$hsbc), [$bbt](/topic/$bbt), [$dcth](/topic/$dcth), [$vktx](/topic/$vktx), [superrare](/topic/superrare), [superrarebears](/topic/superrarebears), [$atxs](/topic/$atxs), [$cdtx](/topic/$cdtx), [$dhr](/topic/$dhr), [$drug](/topic/$drug), [$pepgs](/topic/$pepgs), [$10b](/topic/$10b), [nasdaq](/topic/nasdaq), [robust](/topic/robust), [upside](/topic/upside), [jpmorgan chase](/topic/jpmorgan-chase), [$cgem](/topic/$cgem), [$rvmd](/topic/$rvmd), [$prqr](/topic/$prqr), [$ions](/topic/$ions), [advanced micro devices](/topic/advanced-micro-devices), [$ocul](/topic/$ocul), [$eypt](/topic/$eypt), [stevie wonder](/topic/stevie-wonder), [momentum](/topic/momentum), [nov inc](/topic/nov-inc), [$nov](/topic/$nov), [$agio](/topic/$agio), [$jade](/topic/$jade), [$kros](/topic/$kros), [$rapt](/topic/$rapt), [acquisition](/topic/acquisition), [$etnb](/topic/$etnb), [stocks industrials](/topic/stocks-industrials), [$mktx](/topic/$mktx), [$alhc](/topic/$alhc), [$fn](/topic/$fn), [$oust](/topic/$oust), [$dbrg](/topic/$dbrg), [$wfc](/topic/$wfc), [$mara](/topic/$mara), [$rytm](/topic/$rytm), [$onc](/topic/$onc), [$incy](/topic/$incy), [$clrb](/topic/$clrb), [$huma](/topic/$huma), [$ngne](/topic/$ngne), [$asnd](/topic/$asnd), [$novo](/topic/$novo), [$bmyorbital](/topic/$bmyorbital), [$mplt](/topic/$mplt), [ipo](/topic/ipo), [breakthrough](/topic/breakthrough), [$glto](/topic/$glto), [$tmq](/topic/$tmq), [$znb](/topic/$znb), [$coch](/topic/$coch), [$fsm](/topic/$fsm), [$tlry](/topic/$tlry), [$wyhg](/topic/$wyhg), [$qvcgb](/topic/$qvcgb), [$lot](/topic/$lot), [$cmtg](/topic/$cmtg), [$vsta](/topic/$vsta), [$ptct](/topic/$ptct), [outlook](/topic/outlook), [discussions](/topic/discussions), [$anix](/topic/$anix)

### Top Social Posts [#](/topic/dyne-therapeutics/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$10B.that is the combined market cap of major DM1 players $RNA $DYN and $PEPG; add to this $VRTX w/ a approach and stage similar to $PEPG. $RNA also prices in large FSHD opportunity. DM1 is one of the largest genetic disease categories larger than CF. Combined market cap could ultimately be $50B in 2029. There is also likely a succession of therapies coming onto market that improve on earlier approved drugs: 1) $RNA: most advanced evidence of fct improvements but probably least effective on molecular level (CASI) 2) $DYN: a year behind $RNA but CASI superior and impressive fct data at WMS25"  
[X Link](https://x.com/RNAiAnalyst/status/1978743257090642124) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2025-10-16T08:42Z 20.5K followers, 4732 engagements


"Down-to-earth data-based discussion of $pepg's DM1 program safety and efficacy. $dyn $rna"  
[X Link](https://x.com/RNAiAnalyst/status/1978588482315378977) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2025-10-15T22:27Z 20.5K followers, 8575 engagements


"$DYN Analyst price targets for tomorrow .🎯"  
[X Link](https://x.com/StewarT36463950/status/1978582096525316192) [@StewarT36463950](/creator/x/StewarT36463950) 2025-10-15T22:01Z XXX followers, XX engagements


"$DYN 🔹 +7.12% peak gain from prior close 🔹 +6.23% peak gain from open 🔹 1.3x relative volume Before you bid consult the Ledger"  
[X Link](https://x.com/thealphaledger/status/1978568667165065503) [@thealphaledger](/creator/x/thealphaledger) 2025-10-15T21:08Z XX followers, XXX engagements